1.
Sacha T. Superior efficacy of nilotinib vs imatinib in patients with chronic myeloid leukemia in chronic phase. ENESTnd and ENESTcmr current results analysis. OncoReview [Internet]. 2013Mar.29 [cited 2024Nov.23];3(1(9):37-5. Available from: https://journalsmededu.pl/index.php/OncoReview/article/view/328